SCHEMBL2445220

SCHEMBL2445220

O=C(O)C1CCC(=O)N1Cc1cccs1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.53
ALDH1A1 P00352 6/20 0.45
SIGMAR1 Q99720 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
MCHR1 Q99705 1/20 0.42
KMT2A Q03164 3/20 0.42
HSD17B10 Q99714 2/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
GBA1 P04062 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
P2RX7 Q99572 1/20 0.41
POLB P06746 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445215 1.00 L3MBTL1 (0.53) L3MBTL1ALDH1A1SIGMAR1NPSR1MCHR1
SCHEMBL14628034 0.78 ALDH1A1 (0.45) L3MBTL1ALDH1A1NPSR1MCHR1KMT2A
SCHEMBL288652 0.78 P2RX7 (0.56) ALDH1A1KMT2AP2RX7
SCHEMBL289574 0.78 P2RX7 (0.56) ALDH1A1KMT2AP2RX7
SCHEMBL288651 0.78 P2RX7 (0.56) ALDH1A1KMT2AP2RX7
SCHEMBL19974768 0.77 KMT2A (0.43) ALDH1A1KMT2ASMN1; SMN2KDM4EPKM
SCHEMBL14943220 0.76 PKM (0.45) L3MBTL1ALDH1A1NPSR1MCHR1KMT2A
SCHEMBL7217950 0.76 HTT (0.48) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL289312 0.75 HTT (0.65) ALDH1A1KMT2AMAPTMEN1P2RX7
SCHEMBL16601374 0.75 P2RX7 (0.59) ALDH1A1SIGMAR1KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed